GLYCOBIDUO
Live / Registered — Registered (as of 28 Jul 2026)
What this means for you
Registered since 28 Jul 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Jul 2032: the §8 declaration of use).
Record
- Serial number
- 99166457
- Registration number
- 8363213
- Mark type
- Design + words
- Filed
- 01 May 2025
- Published for opposition
- 09 Jun 2026
- Registered
- 28 Jul 2026
- Next maintenance filing
- §8 declaration of use, due by 28 Jul 2032 (grace period to 28 Jan 2033)
- Attorney of record
- Ran He
Goods and services
- Class 005 — Pharmaceuticals: Immunostimulants; Chemical reagents for medical or veterinary purposes; Enzymes for medical purposes; Vaccines; Hormones for medical purposes; Adjuvants for medical purposes; Ferments for pharmaceutical purposes; Enzyme preparations for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for use in chemotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Pharmaceutical preparations for the treatment and prevention of cancer to be treated; Preparations of microorganisms for medical purposes
Owner
- OBI PHARMA, INC., Taipei City, TW
- OBI PHARMA, INC., Taipei City, TW
- OBI PHARMA, INC., Taipei City, TW
Prosecution history
- 28 Jul 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jul 2026 — REGISTERED-PRINCIPAL REGISTER
- 09 Jun 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jun 2026 — PUBLISHED FOR OPPOSITION
- 03 Jun 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 May 2026 — CASE RETURNED TO EXAMINATION
- 14 May 2026 — NOTICE OF ALLOWANCE CANCELLED
- 01 May 2026 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 01 May 2026 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 30 Apr 2026 — ASSIGNED TO PETITION STAFF
- 13 Mar 2026 — TEAS PETITION TO AMEND BASIS RECEIVED
- 02 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Oct 2025 — PUBLISHED FOR OPPOSITION
- 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED